Bemiparin sodium
Bemiparin Sodium
Bemiparin sodium (pronunciation: be-mi-par-in so-di-um) is a type of anticoagulant or blood thinner that is used to prevent and treat blood clots. It is a low molecular weight heparin (LMWH) that is derived from standard heparin.
Etymology
The term "Bemiparin" is derived from the words "bemi" and "parin". "Bemi" is a prefix used in pharmacology to denote a drug that is a derivative of another drug. "Parin" is derived from the word "heparin", which is the parent drug of bemiparin. The term "sodium" refers to the sodium salt form of the drug.
Pharmacology
Bemiparin sodium works by inhibiting the activity of certain clotting factors in the blood, thereby preventing the formation of blood clots. It is more selective than standard heparin, primarily affecting factor Xa and to a lesser extent, factor IIa.
Indications
Bemiparin sodium is used in the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used in the prevention of clotting in the extracorporeal circuit during hemodialysis.
Side Effects
Like other anticoagulants, bemiparin sodium can cause bleeding. Other side effects may include bruising, allergic reactions, and osteoporosis with long-term use.
Related Terms
- Anticoagulant
- Blood thinner
- Blood clot
- Heparin
- Clotting factors
- Deep vein thrombosis
- Pulmonary embolism
- Hemodialysis
- Bruising
- Allergic reactions
- Osteoporosis
External links
- Medical encyclopedia article on Bemiparin sodium
- Wikipedia's article - Bemiparin sodium
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski